Sign in
4

Changes in Ownership

Wave Life Sciences, Inc. Filed Acc 0000950170-24-042381

Chief Financial Officer sold 15,630 shares at $6.17 ($96,421)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Moran Kyle · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-04-03 Sale : show line 1 in the form 10b5-1 −15,630 $6.17 $96,421 33,921 D
Open-market sales · 15,630 sh · avg $6.17 · $96,421
Loading xslF345X05/ownership.xml…